Health and Healthcare
5867 Articles
Osiris Therapeutics, Inc. (NASDAQ: OSIR) is seeing its stock getting pounded this morning. The company announced that it was ending…
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover…
The hope for a higher Genentech Inc. (NYSE: DNA) buyout price is getting smaller and smaller. After the companies agreed…
Gilead Sciences, Inc. (Nasdaq: GILD) has agreed to buy CV Therapeutics, Inc. (Nasdaq: CVTX) for $20.00 per share in cash.
Pfizer Inc. (NYSE: PFE) is stopping its Phase III clinical trial of Sutent early. This is generally a scare over…
Before Roche decided to try to buy the 44% of biotech company Genentech (DNA) that it did not already own…
Pfizer Inc. (NYSE: PFE) just got its long-term ratings downgraded by Moody’s. It is amazing that bond ratings agencies still…
The AMA, the federal government, and most insurance companies and HMOs have been arguing that storing and updating medical records…
Merck (MRK) is merging with Schering-Plough (SGP) in a deal that the companies say is worth $41.1 billion. In reality,…
Roche has apparently capitulated in its fight to take over Genentech Inc. (NYSE: DNA). Its cancer franchise and its pipeline,…
We are seeing unusual trading activity so far this morning in shares of Dendreon Corp. (NASDAQ: DNDN), Genentech, Inc. (NYSE:…
For years, Americans have assumed that the FDA was set up to test drugs. If a treatment was not effective…
How long has it been since a company announced a stock split? More importantly, when was the last from a…
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know…
Geron Corporation (NASDAQ: GERN) had a filing to sell shares that hit after teh close today. Normally this would be…
Our top personal finance-related articles today. Your wallet will thank you later.